Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

Similar articles for PubMed (Select 19455139)

1.

Migration rules: tumours are conglomerates of self-metastases.

Enderling H, Hlatky L, Hahnfeldt P.

Br J Cancer. 2009 Jun 16;100(12):1917-25. doi: 10.1038/sj.bjc.6605071. Epub 2009 May 19.

2.

Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics.

Enderling H, Anderson AR, Chaplain MA, Beheshti A, Hlatky L, Hahnfeldt P.

Cancer Res. 2009 Nov 15;69(22):8814-21. doi: 10.1158/0008-5472.CAN-09-2115. Epub 2009 Nov 3.

3.

Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line.

Senior PV, Zhang BX, Chan ST.

Int J Colorectal Dis. 2010 Jun;25(6):687-94. doi: 10.1007/s00384-010-0916-7. Epub 2010 Mar 26.

PMID:
20339854
4.

Using a stem cell and progeny model to illustrate the relationship between cell cycle times of in vivo human tumour cell tissue populations, in vitro primary cultures and the cell lines derived from them.

Daukste L, Basse B, Baguley BC, Wall DJ.

J Theor Biol. 2009 Oct 21;260(4):563-71. doi: 10.1016/j.jtbi.2009.06.019. Epub 2009 Jun 30. Erratum in: J Theor Biol. 2011 Nov 21;289:269.

PMID:
19573536
5.

Defining the mode of tumour growth by clonal analysis.

Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C.

Nature. 2012 Aug 23;488(7412):527-30. doi: 10.1038/nature11344.

PMID:
22854777
6.

Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion.

Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz i Altaba A.

EMBO Mol Med. 2009 Sep;1(6-7):338-51. doi: 10.1002/emmm.200900039.

7.

Experimental chemotherapy and concepts related to the cell cycle.

Tannock IF.

Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Feb;49(2):335-55. Review.

PMID:
3510996
8.

Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.

Darini CY, Pisani DF, Hofman P, Pedeutour F, Sudaka I, Chomienne C, Dani C, Ladoux A.

Oncogene. 2012 May 10;31(19):2438-49. doi: 10.1038/onc.2011.421. Epub 2011 Sep 19.

PMID:
21927026
9.

Identification and expansion of human colon-cancer-initiating cells.

Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R.

Nature. 2007 Jan 4;445(7123):111-5. Epub 2006 Nov 19.

PMID:
17122771
10.

Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.

Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O, Abel U, Arens A, Weichert W, Brand K, Koch M, Weitz J, Schmidt M, von Kalle C, Glimm H.

Cell Stem Cell. 2011 Oct 4;9(4):357-65. doi: 10.1016/j.stem.2011.08.010.

11.

The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.

Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G, Pirozzi G.

Eur J Cardiothorac Surg. 2009 Sep;36(3):446-53. doi: 10.1016/j.ejcts.2009.03.063. Epub 2009 May 22.

PMID:
19464919
12.
13.

The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progression.

Enderling H, Hlatky L, Hahnfeldt P.

Math Med Biol. 2012 Mar;29(1):21-9. doi: 10.1093/imammb/dqq015. Epub 2010 Oct 6.

PMID:
20929852
14.

Tumour stem cell-targeted treatment: elimination or differentiation.

Massard C, Deutsch E, Soria JC.

Ann Oncol. 2006 Nov;17(11):1620-4. Epub 2006 May 3. Review.

15.

Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.

Kaminski A, Hahne JC, Haddouti el-M, Florin A, Wellmann A, Wernert N.

Int J Mol Med. 2006 Nov;18(5):941-50.

PMID:
17016625
16.

Cancer stem cells: problems for therapy?

Alison MR, Lim SM, Nicholson LJ.

J Pathol. 2011 Jan;223(2):147-61. doi: 10.1002/path.2793. Epub 2010 Oct 25. Review. Erratum in: J Pathol. 2012 Feb;226(3):e1.

PMID:
21125672
17.

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

O'Brien CA, Pollett A, Gallinger S, Dick JE.

Nature. 2007 Jan 4;445(7123):106-10. Epub 2006 Nov 19.

PMID:
17122772
18.

Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity.

Swartz MA, Kristensen CA, Melder RJ, Roberge S, Calautti E, Fukumura D, Jain RK.

Br J Cancer. 1999 Nov;81(5):756-9.

19.

Cancer stem cells and tumor dormancy.

Enderling H.

Adv Exp Med Biol. 2013;734:55-71. doi: 10.1007/978-1-4614-1445-2_4.

PMID:
23143975
20.

Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.

Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, Moore PA.

Br J Cancer. 2010 Apr 13;102(8):1265-75. doi: 10.1038/sj.bjc.6605610. Epub 2010 Mar 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk